ENCODE biosample ENCBS605JYS

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADD3

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS605JYS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADD3. (ADD3-BGHcLV25-14)


ENCODE biosample ENCBS606ENA

status: PUBLIC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 90 or above year

tag: attribute

characteristic: age

text: Homo sapiens male adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: male

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS606ENA: human_brain_Rush ID_E2987202_BS122_ENC4_cDNA684

characteristic: title


ENCODE biosample ENCBS607GSW

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDC5L

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS607GSW: RNA-seq on K562 cells treated with a CRISPR gRNA against CDC5L. (CDC5L-BGKcLV28-12)


ENCODE biosample ENCBS611ZGG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 78 year

text: Homo sapiens male adult (78 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS611ZGG: human_brain_Rush ID_E2129371_BS142_ENC4_cDNA692


ENCODE biosample ENCBS612UJI

text: ENCODE

text: live

text: Generic

text: 86 year

characteristic: age

text: Homo sapiens male adult (86 years) middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

text: male

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS612UJI: human_brain_Rush ID_E8969200_BS188_ENC4_cDNA742


ENCODE biosample ENCBS612ZRN

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG7

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS612ZRN: RNA-seq on K562 cells treated with a CRISPR gRNA against SF3B3. (SF3B3-BGKcLV33-54)

characteristic: title


ENCODE biosample ENCBS615UOZ

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens A673 cell line, subjected to a 6 hour pulse-chase

text: child

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS615UOZ


ENCODE biosample ENCBS616JKY

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 50 year

text: activated naive CD4-positive, alpha-beta T cell

characteristic: cell type

text: Homo sapiens male adult (50 years) activated naive CD4-positive, alpha-beta T primary cell treated with 50 U/mL Interleukin-2 for 72 hours, anti-CD3 and anti-CD28 coated beads for 72 hours

text: adult

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS616JKY

text: treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 72; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS617OXH

text: ENCODE

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SCAF8

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS617OXH: RNA-seq on K562 cells treated with a CRISPR gRNA against SAMHD1. (SAMHD1-BGKcLV33-28)


ENCODE biosample ENCBS617TDS

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AHCYL2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS617TDS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against AHCYL2. (AHCYL2-BGHcLV25-22)

characteristic: title


ENCODE biosample ENCBS618IFP

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS15A

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS618IFP: RNA-seq on K562 cells treated with a CRISPR gRNA against RPS15A. (RPS15A-BGKcLV30-67)


ENCODE biosample ENCBS620CUH

text: ENCODE

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLTC

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS620CUH: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CLTC. (CLTC-BGHcLV29-23)


ENCODE biosample ENCBS620SIZ

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS620SIZ: RNA-seq on human cell line K562

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS621TYJ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SARNP

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS621TYJ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SARNP. (SARNP-BGHcLV31-27)

characteristic: title


ENCODE biosample ENCBS622KXD

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS622KXD: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV27-1)


ENCODE biosample ENCBS622OPD

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 4 hours, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS622OPD: RNA-seq on human cell line K562

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS622XGP

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 30 year

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

text: adult

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Coriell

text: ENCODE biosample ENCBS622XGP: iPSC


ENCODE biosample ENCBS623ENG

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 25 year

text: Homo sapiens Calu3 cell line, subjected to a 2 hour pulse-chase

text: adult

text: Lung adenocarcinoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS623ENG

characteristic: title


ENCODE biosample ENCBS625ZVV

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

characteristic: age

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM DMSO (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS625ZVV

text: treatment_term_id: CHEBI:28262; treatment_term_name: DMSO; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS626EZN

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ELAC2

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS626EZN: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ELAC2. (ELAC2-BGHcLV24-32)


ENCODE biosample ENCBS626OCD

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 48 year

text: Homo sapiens OCI-LY7 cell line treated with 500 rad irradiation

text: adult

text: B cell lymphoma

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: DSMZ

text: ENCODE biosample ENCBS626OCD

text: treatment_term_name: irradiation; treatment_type: irradiation;


ENCODE biosample ENCBS626ZIO

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS626ZIO: human_brain_Rush ID_E9687283_BS217_ENC4_cDNA772

characteristic: title


ENCODE biosample ENCBS627QRR

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SAP30BP

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS627QRR: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SAP30BP. (SAP30BP-BGHcLV31-25)


ENCODE biosample ENCBS627XLY

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 24 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS627XLY: RNA-seq on human cell line K562

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS628VDP

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RIOK2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS628VDP: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RIOK2. (RIOK2-BGHcLV32-34B)


ENCODE biosample ENCBS629JYA

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AIMP1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS629JYA: RNA-seq on K562 cells treated with a CRISPR gRNA against AIMP1. (AIMP1-BGKcLV26-19)

characteristic: title


ENCODE biosample ENCBS630AAA

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: cell line

text: Homo sapiens GM12878 cell line

characteristic: description

text: adult

characteristic: dev stage

text: Unknown Lab

text: Homo sapiens

text: cell line

text: female

text: Coriell

text: ENCODE biosample ENCBS630AAA: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus


ENCODE biosample ENCBS631QFV

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 51 year

text: Homo sapiens male adult (51 years) heart left ventricle tissue, preserved by flash-freezing

text: adult

characteristic: donor ID

text: LMNA-related dilated cardiomyopathy (EF 27.9%, LVEDD 6.1, LVPWd 1.3)

characteristic: health state

text: Michael Snyder, Stanford

text: Homo sapiens

text: tissue

text: male

text: Shin Lin

text: heart left ventricle

characteristic: tissue

text: ENCODE biosample ENCBS631QFV: Homo sapiens heart left ventricle tissue


ENCODE biosample ENCBS632MXM

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS15A

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS632MXM: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPS15A. (RPS15A-BGHcLV32-66)


ENCODE biosample ENCBS633IOB

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPRD1B

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS633IOB: RNA-seq on K562 cells treated with a CRISPR gRNA against RPRD1B. (RPRD1B-BGKcLV30-59)

characteristic: title


ENCODE biosample ENCBS634GPK

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 19 year

text: mammary epithelial cell

characteristic: cell type

text: Homo sapiens female adult (19 years) mammary epithelial primary cell, subjected to a 2 hour pulse-chase

characteristic: description

text: adult

characteristic: dev stage

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

text: female

text: Lonza

text: ENCODE biosample ENCBS634GPK


ENCODE biosample ENCBS634TDN

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPRD1B

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS634TDN: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPRD1B. (RPRD1B-BGHcLV32-58)


ENCODE biosample ENCBS634VGA

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 85 year

text: Homo sapiens male adult (85 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS634VGA: human_brain_Rush ID_E1703237_BS141_ENC4_cDNA691


ENCODE biosample ENCBS636MAC

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCDC47

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS636MAC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CCDC47. (CCDC47-BGHcLV27-46)

characteristic: title


ENCODE biosample ENCBS637VLU

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CTCF treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS637VLU

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS639AFY

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARHSP1

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS639AFY: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CARHSP1. (CARHSP1-BGHcLV27-38)


ENCODE biosample ENCBS639LVM

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CWF19L2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS639LVM: RNA-seq on K562 cells treated with a CRISPR gRNA against CWF19L2. (CWF19L2-BGKcLV28-55)


ENCODE biosample ENCBS643AJQ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 47 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (47 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

text: Donor with Amyotrophic Lateral Sclerosis

text: Michael Snyder, Stanford

text: Homo sapiens

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

characteristic: source

text: ENCODE biosample ENCBS643AJQ: RNA-seq on human

characteristic: title


ENCODE biosample ENCBS643OTR

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 nM Bortezomib for 24 hours, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS643OTR: RNA-seq on human cell line K562

text: treatment_term_id: CHEBI:52717; treatment_term_name: Bortezomib; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS644WSW

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 90 or above year

text: Homo sapiens male adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS644WSW: human_brain_Rush ID_4368365_BS62_ENC4_cDNA651


ENCODE biosample ENCBS645RJM

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLTC

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS645RJM: RNA-seq on K562 cells treated with a CRISPR gRNA against CLTC. (CLTC-BGKcLV28-24)


ENCODE biosample ENCBS645VXU

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens RAD21

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS645VXU

characteristic: title


ENCODE biosample ENCBS646XIM

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 50 uM C646 for 12 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS646XIM: RNA-seq on human cell line K562

text: treatment_term_name: C646; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS647AAA

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: keratinocyte

characteristic: cell type

text: Homo sapiens female keratinocyte primary cell cytosolic fraction

text: Thomas Gingeras, CSHL

text: Homo sapiens

text: primary cell

characteristic: sample type

text: female

text: Lonza

text: cytosol

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS647AAA: epidermal keratinocytes


ENCODE biosample ENCBS648AAA

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: keratinocyte

text: Homo sapiens female keratinocyte primary cell nuclear fraction

text: Thomas Gingeras, CSHL

text: Homo sapiens

text: primary cell

text: female

characteristic: sex

text: Lonza

text: nucleus

text: ENCODE biosample ENCBS648AAA: epidermal keratinocytes


ENCODE biosample ENCBS651VNU

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ALDOA

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS651VNU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ALDOA. (ALDOA-BGHcLV27-7)


ENCODE biosample ENCBS652DFI

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens APEH

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS652DFI: RNA-seq on K562 cells treated with a CRISPR gRNA against APEH. (APEH-BGKcLV26-26)

characteristic: title


ENCODE biosample ENCBS652ECV

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM25

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS652ECV: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RBM25. (RBM25-BGHcLV32-9)


ENCODE biosample ENCBS652ENJ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS652ENJ: human_brain_Rush ID_E3760550_BS198_ENC4_cDNA753


ENCODE biosample ENCBS652IYM

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BZW2

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS652IYM: RNA-seq on K562 cells treated with a CRISPR gRNA against BZW2. (BZW2-BGKcLV26-46)


ENCODE biosample ENCBS652MTO

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM RU486 (agonist) for 4 hours

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS652MTO

characteristic: title

text: treatment_term_id: CHEBI:50692; treatment_term_name: RU486; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS652UVX

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SAP30BP

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS652UVX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SAP30BP. (SAP30BP-BGHcLV31-26)


ENCODE biosample ENCBS654QXD

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens RAD21

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS654QXD


ENCODE biosample ENCBS657JNU

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SPAG9

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS657JNU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SPAG9. (SPAG9-BGHcLV31-63)


ENCODE biosample ENCBS659OBX

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAT

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS659OBX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CAT. (CAT-BGHcLV27-43)

characteristic: title


ENCODE biosample ENCBS660AUE

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS660AUE: human_brain_Rush ID_6341028_BS46_ENC4_cDNA656


ENCODE biosample ENCBS662RQC

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CMTR1

characteristic: description

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS662RQC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CMTR1. (CMTR1-BGHcLV29-25)


ENCODE biosample ENCBS662ZJB

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 50 uM C646 for 12 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS662ZJB: RNA-seq on human cell line K562

text: treatment_term_name: C646; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS663RQN

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCT2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS663RQN: RNA-seq on K562 cells treated with a CRISPR gRNA against CCT2. (CCT2-BGKcLV28-4)

characteristic: title


ENCODE biosample ENCBS664UYP

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens PSMA1

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS664UYP: RNA-seq on HepG2 cells treated with a CRISPR gRNA against PSMA1. (PSMA1-BGHcLV25-52)


ENCODE biosample ENCBS665FPO

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS9

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS665FPO: RNA-seq on K562 cells treated with a CRISPR gRNA against CDC42EP4. (CDC42EP4-BGKcLV33-7)


ENCODE biosample ENCBS665LKP

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours

text: adult

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS665LKP: HL-60 derived M0 macrophages

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS666KAY

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 87 year

text: Homo sapiens male adult (87 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS666KAY: human_brain_Rush ID_7204277_BS105_ENC4_cDNA659

characteristic: title


ENCODE biosample ENCBS667CTF

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SMARCA5 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

characteristic: description

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS667CTF

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS667JAR

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 5 uM JQ1 for 24 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS667JAR: RNA-seq on human cell line K562

text: treatment_term_name: JQ1; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS669SHO

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 5 uM MB-3 for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS669SHO: RNA-seq on human cell line K562

text: treatment_term_name: MB-3; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS671GNG

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AGFG1

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS671GNG: RNA-seq on HepG2 cells treated with a CRISPR gRNA against AGFG1. (AGFG1-BGHcLV25-20)

characteristic: title


ENCODE biosample ENCBS671RRR

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: motor neuron

characteristic: cell type

text: Homo sapiens female adult motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: Healthy donor

text: Michael Snyder, Stanford

text: Homo sapiens

text: in vitro differentiated cells

characteristic: sample type

text: female

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS671RRR: RNA-seq on human


ENCODE biosample ENCBS672NOQ

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 36 year

text: MCF 10A

text: Homo sapiens MCF 10A cell line, subjected to a 6 hour pulse-chase

text: adult

text: fibrocystic disease

characteristic: health state

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS672NOQ


ENCODE biosample ENCBS673YTO

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens EIF6

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS673YTO: RNA-seq on HepG2 cells treated with a CRISPR gRNA against EIF6. (EIF6-BGHcLV24-29)


ENCODE biosample ENCBS675FWG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 89 year

text: Homo sapiens female adult (89 years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS675FWG: human_brain_Rush ID_8074960_BS43_ENC4_cDNA658

characteristic: title


ENCODE biosample ENCBS675YCF

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: motor neuron

characteristic: cell type

text: adult

characteristic: dev stage

characteristic: donor ID

text: Healthy donor

text: Michael Snyder, Stanford

text: Homo sapiens

text: in vitro differentiated cells

characteristic: sample type

text: female

text: ENCODE biosample ENCBS675YCF: RNA-seq on human


ENCODE biosample ENCBS676SDY

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAST

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS676SDY: RNA-seq on K562 cells treated with a CRISPR gRNA against CAST. (CAST-BGKcLV26-59)


ENCODE biosample ENCBS679VZQ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM CORT108297 (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS679VZQ

text: treatment_term_name: CORT108297; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS680RXP

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 58 year

text: adult

characteristic: dev stage

characteristic: donor ID

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS680RXP

characteristic: title


ENCODE biosample ENCBS681WMY

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 10 nM Bortezomib for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS681WMY: RNA-seq on human cell line K562

text: treatment_term_id: CHEBI:52717; treatment_term_name: Bortezomib; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS682DUG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: cell line

text: Homo sapiens PC-9 cell line, subjected to a 6 hour pulse-chase

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: not collected

characteristic: sex

text: Sigma

text: ENCODE biosample ENCBS682DUG


ENCODE biosample ENCBS682MKT

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line treated with 10 uM AR-42 for 48 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS682MKT: RNA-seq on human cell line K562

text: treatment_term_name: AR-42; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS682RDL

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 88 year

text: Homo sapiens female adult (88 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS682RDL: human_brain_Rush ID_E3648984_BS196_ENC4_cDNA751

characteristic: title


ENCODE biosample ENCBS685GIE

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS685GIE: human_brain_Rush ID_E5387473_BS202_ENC4_cDNA757


ENCODE biosample ENCBS686VHT

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLASP2

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS686VHT: RNA-seq on K562 cells treated with a CRISPR gRNA against CLASP2. (CLASP2-BGKcLV28-20)


ENCODE biosample ENCBS687KKD

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

text: ENCODE biosample ENCBS687KKD: human_brain_Rush ID_E9876975_BS193_ENC4_cDNA747


ENCODE biosample ENCBS687PHC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM GW870086 (agonist) for 4 hours

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS687PHC

characteristic: title

text: treatment_term_name: GW870086; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS687QFM

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

text: John Lis, Cornell

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS687QFM


ENCODE biosample ENCBS689EVR

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens APTX

characteristic: description

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS689EVR: RNA-seq on HepG2 cells treated with a CRISPR gRNA against APTX. (APTX-BGHcLV24-11)


ENCODE biosample ENCBS692PXQ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS692PXQ: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV29-2)


ENCODE biosample ENCBS692WQE

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF2

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS692WQE: RNA-seq on K562 cells treated with a CRISPR gRNA against CPSF2. (CPSF2-BGKcLV28-34)

characteristic: title


ENCODE biosample ENCBS692XVD

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RNPC3

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS692XVD: RNA-seq on K562 cells treated with a CRISPR gRNA against RNPC3. (RNPC3-BGKcLV30-41)


ENCODE biosample ENCBS692ZUT

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SUPT16H

characteristic: description

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS692ZUT


ENCODE biosample ENCBS695AAR

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEPT7

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS695AAR: RNA-seq on K562 cells treated with a CRISPR gRNA against SEC63. (SEC63-BGKcLV33-42)


ENCODE biosample ENCBS695AYB

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM CORT108297 (agonist) for 4 hours

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS695AYB

text: treatment_term_name: CORT108297; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS696MEH

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 35 year

characteristic: age

text: activated T-helper 2 cell

characteristic: cell type

text: Homo sapiens male adult (35 years) activated T-helper 2 primary cell treated with 5 ug/mL Interferon-gamma antibody for 36 hours, anti-CD3 and anti-CD28 coated beads for 24 hours, 10 ng/mL Interleukin-2 for 14 days, anti-CD3 and anti-CD28 coated beads for 14 days, 100 ng/mL Interleukin-4 for 36 hours

text: adult

text: Yijun Ruan, JAX

text: Homo sapiens

text: primary cell

characteristic: sample type

text: male

text: AllCells

text: ENCODE biosample ENCBS696MEH

characteristic: title

text: treatment_term_name: Interferon-gamma antibody; treatment_type: antibody; duration: 36; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 24; duration_units: hour; treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 14; duration_units: day; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 14; duration_units: day; treatment_term_id: UniProtKB:P05112; treatment_term_name: Interleukin-4; treatment_type: protein; duration: 36; duration_units: hour;


ENCODE biosample ENCBS697LCA

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX18

characteristic: description

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS697LCA: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DDX18. (DDX18-BGHcLV29-72)


ENCODE biosample ENCBS698KGE

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 21 year

text: T-cell

text: Homo sapiens female adult (21 years) T-cell primary cell

text: adult

characteristic: dev stage

text: John Stamatoyannopoulos, UW

text: Homo sapiens

characteristic: organism

text: primary cell

text: female

text: StemExpress

text: ENCODE biosample ENCBS698KGE


ENCODE biosample ENCBS701GNL

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 48 year

characteristic: age

text: Homo sapiens OCI-LY7 cell line, subjected to a 6 hour pulse-chase

text: adult

characteristic: donor ID

text: B cell lymphoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: DSMZ

characteristic: source

text: ENCODE biosample ENCBS701GNL


ENCODE biosample ENCBS702UDW

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS702UDW

characteristic: title


ENCODE biosample ENCBS703JUW

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS8

characteristic: description

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS703JUW: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPS8. (RPS8-BGHcLV31-9)


ENCODE biosample ENCBS703VDG

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 24 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS703VDG: RNA-seq on human cell line K562

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS704KLT

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 84 year

characteristic: age

text: Homo sapiens male adult (84 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: male

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS704KLT: human_brain_Rush ID_E2804864_BS180_ENC4_cDNA734


ENCODE biosample ENCBS704YXU

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: endothelial cell of umbilical vein

characteristic: cell type

text: Homo sapiens male newborn endothelial of umbilical vein primary cell, subjected to a 6 hour pulse-chase

characteristic: description

text: newborn

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

characteristic: sample type

text: male

text: Lonza

text: ENCODE biosample ENCBS704YXU

characteristic: title


ENCODE biosample ENCBS705JBM

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 72 year

characteristic: cell line

text: Homo sapiens Caco-2 cell line, subjected to a 6 hour pulse-chase

text: adult

text: colorectal adenocarcinoma

characteristic: health state

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS705JBM


ENCODE biosample ENCBS705PFV

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 48 year

characteristic: age

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens POLR2A

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS705PFV


ENCODE biosample ENCBS706VCU

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 100 ng/mL lipopolysaccharide for 12 hours, 100 ng/mL interferon gamma for 12 hours

characteristic: description

text: adult

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS706VCU: HL-60 derived M1 macrophages (12hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: CHEBI:16412; treatment_term_name: lipopolysaccharide; treatment_type: chemical; duration: 12; duration_units: hour; treatment_term_id: UniProtKB:P01579; treatment_term_name: interferon gamma; treatment_type: protein; duration: 12; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS706ZAQ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BRD2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS706ZAQ: RNA-seq on K562 cells treated with a CRISPR gRNA against BRD2. (BRD2-BGKcLV26-41)

characteristic: title


ENCODE biosample ENCBS709FQH

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 87 year

characteristic: age

text: Homo sapiens male adult (87 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: male

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS709FQH: human_brain_Rush ID_7204277_BS116_ENC4_cDNA666


ENCODE biosample ENCBS709SAZ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DCTN2

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS709SAZ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DCTN2. (DCTN2-BGHcLV29-65)


ENCODE biosample ENCBS710OBZ

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 48 year

text: activated naive CD4-positive, alpha-beta T cell

characteristic: cell type

text: Homo sapiens male adult (48 years) activated naive CD4-positive, alpha-beta T primary cell treated with 50 U/mL Interleukin-2 for 72 hours, anti-CD3 and anti-CD28 coated beads for 72 hours

characteristic: description

text: adult

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

characteristic: sample type

text: male

text: StemExpress

text: ENCODE biosample ENCBS710OBZ

text: treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 72; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS711EJM

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPUSD2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS711EJM: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPUSD2. (RPUSD2-BGHcLV31-14)

characteristic: title


ENCODE biosample ENCBS711XJR

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCT3

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS711XJR: RNA-seq on K562 cells treated with a CRISPR gRNA against CCT3. (CCT3-BGKcLV28-5)


ENCODE biosample ENCBS712HXB

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ROCK2

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS712HXB: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ROCK2. (ROCK2-BGHcLV32-41)


ENCODE biosample ENCBS715AAA

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line chromatin fraction

text: adult

text: chronic myelogenous leukemia (CML)

text: Thomas Gingeras, CSHL

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: chromatin

characteristic: subcellular fraction term name

text: ENCODE biosample ENCBS715AAA: leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC


ENCODE biosample ENCBS715ACJ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 30 year

text: Homo sapiens WTC11 cell line, 5 days post differentiation, preserved by flash-freezing

text: adult

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Coriell

text: ENCODE biosample ENCBS715ACJ: iPSC differentiation in to cardiomycytes

characteristic: title


ENCODE biosample ENCBS718ILE

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 55 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (55 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: Healthy donor

characteristic: health state

text: Michael Snyder, Stanford

text: Homo sapiens

characteristic: organism

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

characteristic: source

text: ENCODE biosample ENCBS718ILE: RNA-seq on human


ENCODE biosample ENCBS718XWF

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADK

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS718XWF: RNA-seq on K562 cells treated with a CRISPR gRNA against ADK. (ADK-BGKcLV26-12)


ENCODE biosample ENCBS720JSN

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACO2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS720JSN: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ACO2. (ACO2-BGHcLV25-3)


ENCODE biosample ENCBS721KTA

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 75 year

text: Homo sapiens female adult (75 years) middle frontal area 46 tissue

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS721KTA: human_brain_Rush ID_E6590998_BS170_ENC4_cDNA720

characteristic: title


ENCODE biosample ENCBS722LHW

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM DMSO (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS722LHW

text: treatment_term_id: CHEBI:28262; treatment_term_name: DMSO; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS724PTR

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM AZD2906 (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS724PTR

text: treatment_term_name: AZD2906; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS724WJD

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS15A

text: child

characteristic: dev stage

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS724WJD: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPS15A. (RPS15A-BGHcLV32-65)


ENCODE biosample ENCBS725YIG

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLASP2

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS725YIG: RNA-seq on K562 cells treated with a CRISPR gRNA against CLASP2. (CLASP2-BGKcLV28-19)

characteristic: title


ENCODE biosample ENCBS727FRT

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 35 year

text: T-helper 2 cell

characteristic: cell type

text: Homo sapiens male adult (35 years) T-helper 2 primary cell treated with 100 ng/mL Interleukin-4 for 36 hours, 5 ug/mL Interferon-gamma antibody for 36 hours

text: adult

text: Yijun Ruan, JAX

text: Homo sapiens

characteristic: organism

text: primary cell

text: male

text: AllCells

characteristic: source

text: ENCODE biosample ENCBS727FRT

text: treatment_term_id: UniProtKB:P05112; treatment_term_name: Interleukin-4; treatment_type: protein; duration: 36; duration_units: hour; treatment_term_name: Interferon-gamma antibody; treatment_type: antibody; duration: 36; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS727HEC

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens REXO2

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS727HEC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against REXO2. (REXO2-BGHcLV32-29)


ENCODE biosample ENCBS729GGJ

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 6 year

text: motor neuron

text: Homo sapiens male child (6 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: child

characteristic: dev stage

characteristic: donor ID

text: Healthy donor

characteristic: health state

text: Michael Snyder, Stanford

characteristic: lab

text: Homo sapiens

text: in vitro differentiated cells

text: male

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS729GGJ: RNA-seq on human


ENCODE biosample ENCBS729ZZV

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens POLR2A

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS729ZZV

characteristic: title


ENCODE biosample ENCBS732EAU

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

characteristic: age

text: Homo sapiens A549 cell line treated with 1 uM RU486 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS732EAU

text: treatment_term_id: CHEBI:50692; treatment_term_name: RU486; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS733QES

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 5 uM MB-3 for 12 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS733QES: RNA-seq on human cell line K562

text: treatment_term_name: MB-3; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS734EVS

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 41 year

text: natural killer cell

characteristic: cell type

text: Homo sapiens female adult (41 years) natural killer primary cell treated with 100 ng/mL Interleukin-12 subunit alpha for 72 hours, 100 ng/mL Interleukin-15 for 72 hours, 100 ng/mL Interleukin-12 subunit beta for 72 hours, 100 ng/mL Interleukin-18 for 72 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: John Stamatoyannopoulos, UW

characteristic: lab

text: Homo sapiens

text: primary cell

text: female

text: StemExpress

text: ENCODE biosample ENCBS734EVS

text: treatment_term_id: UniProtKB:P29459; treatment_term_name: Interleukin-12 subunit alpha; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P40933; treatment_term_name: Interleukin-15; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P29460; treatment_term_name: Interleukin-12 subunit beta; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:Q14116; treatment_term_name: Interleukin-18; treatment_type: protein; duration: 72; duration_units: hour;


ENCODE biosample ENCBS735BVV

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS735BVV: Control CRISPR gRNA against no target in K562 cells followed by RNA-seq. (NT-BGKcLV28-1)

characteristic: title


ENCODE biosample ENCBS735CVU

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 72 year

characteristic: age

text: Homo sapiens Caco-2 cell line treated with 500 rad irradiation

text: adult

text: colorectal adenocarcinoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS735CVU

text: treatment_term_name: irradiation; treatment_type: irradiation;

characteristic: treatments


ENCODE biosample ENCBS735JRG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS735JRG: human_brain_Rush ID_E1311604_BS172_ENC4_cDNA726


ENCODE biosample ENCBS735KPW

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 5 uM MB-3 for 48 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS735KPW: RNA-seq on human cell line K562

text: treatment_term_name: MB-3; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS735KRY

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DARS

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS735KRY: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DARS. (DARS-BGHcLV29-58)

characteristic: title


ENCODE biosample ENCBS735PLB

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 7.5 nM Panobinostat for 4 hours, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS735PLB: RNA-seq on human cell line K562

text: treatment_term_name: Panobinostat; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS737JKH

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 35 year

text: naive thymus-derived CD4-positive, alpha-beta T cell

characteristic: cell type

text: Homo sapiens male adult (35 years) naive thymus-derived CD4-positive, alpha-beta T primary cell

text: adult

characteristic: donor ID

text: Yijun Ruan, JAX

text: Homo sapiens

text: primary cell

characteristic: sample type

text: male

text: AllCells

text: ENCODE biosample ENCBS737JKH


ENCODE biosample ENCBS738ZPE

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS738ZPE: RNA-seq on human cell line K562

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS739QIE

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens A673 cell line, subjected to a 2 hour pulse-chase

characteristic: description

text: child

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS739QIE

characteristic: title


ENCODE biosample ENCBS739UNB

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM dexamethasone (agonist) for 4 hours

text: adult

characteristic: dev stage

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS739UNB

text: treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS739WYJ

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 50 uM C646 for 24 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS739WYJ: RNA-seq on human cell line K562

text: treatment_term_name: C646; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS742LPB

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: John Lis, Cornell

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS742LPB


ENCODE biosample ENCBS742MVD

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS742MVD: human_brain_Rush ID_4163791_BS53_ENC4_cDNA650

characteristic: title


ENCODE biosample ENCBS742XYV

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 5 uM MB-3 for 12 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS742XYV: RNA-seq on human cell line K562

text: treatment_term_name: MB-3; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS743GHM

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CTCF treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS743GHM

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS744PRW

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CSE1L

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS744PRW: RNA-seq on K562 cells treated with a CRISPR gRNA against CSE1L. (CSE1L-BGKcLV28-44)


ENCODE biosample ENCBS745ELX

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS745ELX: human_brain_Rush ID_E3348003_BS123_ENC4_cDNA685

characteristic: title


ENCODE biosample ENCBS745VSI

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS745VSI

characteristic: treatments


ENCODE biosample ENCBS746ATL

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM Hydrocortisone (agonist) for 4 hours

characteristic: description

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS746ATL

text: treatment_term_id: CHEBI:17650; treatment_term_name: Hydrocortisone; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS747ITB

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 10 uM AR-42 for 4 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS747ITB: RNA-seq on human cell line K562

text: treatment_term_name: AR-42; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS747IVW

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ALDH18A1

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS747IVW: RNA-seq on K562 cells treated with a CRISPR gRNA against ALDH18A1. (ALDH18A1-BGKcLV26-21)

characteristic: title


ENCODE biosample ENCBS747KRV

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 30 year

characteristic: cell line

text: Homo sapiens WTC11 cell line treated with 7.5 uM CHIR 99021 for 48 hours, 2 days post differentiation, preserved by flash-freezing

characteristic: description

text: adult

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

characteristic: source

text: ENCODE biosample ENCBS747KRV: iPSC differentiation in to cardiomycytes

text: treatment_term_id: CHEBI:91091; treatment_term_name: CHIR 99021; treatment_type: chemical; duration: 48; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS749HME

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF3

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS749HME: RNA-seq on K562 cells treated with a CRISPR gRNA against CPSF3. (CPSF3-BGKcLV28-35)


ENCODE biosample ENCBS749YQY

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM dexamethasone (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS749YQY

text: treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS750CKY

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: endothelial cell of umbilical vein

characteristic: cell type

text: Homo sapiens male newborn endothelial of umbilical vein primary cell, subjected to a 6 hour pulse-chase

text: newborn

characteristic: dev stage

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

text: male

text: Lonza

text: ENCODE biosample ENCBS750CKY

characteristic: title